<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/360b" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/360b/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/360b/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_360b"><akn:num>360b</akn:num><akn:heading>New animal drugs</akn:heading><akn:content><akn:p>§ 360b. New animal drugs(a) Unsafe new animal drugs and animal feed containing such drugs; conditions of safety; exemption of drugs for research; import tolerances(1) A new animal drug shall, with respect to any particular use or intended use of such drug, be deemed unsafe for purposes of section 351(a)(5) of this title and section 342(a)(2)(C)(ii) of this title unless—(A) there is in effect an approval of an application filed pursuant to subsection (b) with respect to such use or intended use of such drug, and such drug, its labeling, and such use conform to such approved application;

(B) there is in effect a conditional approval of an application filed pursuant to section 360ccc of this title with respect to such use or intended use of such drug, and such drug, its labeling, and such use conform to such conditionally approved application;

(C) there is in effect an index listing pursuant to section 360ccc–1 of this title with respect to such use or intended use of such drug in a minor species, and such drug, its labeling, and such use conform to such index listing; or

(D) there is in effect an authorization pursuant to section 360bbb–3 of this title with respect to such use or intended use of such drug, and such drug, its labeling, and such use conform to any conditions of such authorization.


A new animal drug shall also be deemed unsafe for such purposes in the event of removal from the establishment of a manufacturer, packer, or distributor of such drug for use in the manufacture of animal feed in any State unless at the time of such removal such manufacturer, packer, or distributor has an unrevoked written statement from the consignee of such drug, or notice from the Secretary, to the effect that, with respect to the use of such drug in animal feed, such consignee (i) holds a license issued under subsection (m) and has in its possession current approved labeling for such drug in animal feed; or (ii) will, if the consignee is not a user of the drug, ship suc</akn:p></akn:content><akn:subsection eId="subsec_360b_a"><akn:num>(a)</akn:num><akn:heading>Unsafe new animal drugs and animal feed containing such drugs; conditions of safety; exemption of drugs for research; import tolerances</akn:heading><akn:content><akn:p>(a) Unsafe new animal drugs and animal feed containing such drugs; conditions of safety; exemption of drugs for research; import tolerances</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_b"><akn:num>(b)</akn:num><akn:heading>Filing application for uses of new animal drug; contents; patent information; abbreviated application; presubmission conference</akn:heading><akn:content><akn:p>(b) Filing application for uses of new animal drug; contents; patent information; abbreviated application; presubmission conference</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_c"><akn:num>(c)</akn:num><akn:heading>Period for submission and approval of application; period for notice and expedition of hearing; period for issuance of order; abbreviated applications; withdrawal periods; effective date of approval; relationship to other applications; withdrawal or suspension of approval; bioequivalence; filing of additional patent information</akn:heading><akn:content><akn:p>(c) Period for submission and approval of application; period for notice and expedition of hearing; period for issuance of order; abbreviated applications; withdrawal periods; effective date of approval; relationship to other applications; withdrawal or suspension of approval; bioequivalence; filing of additional patent information</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_d"><akn:num>(d)</akn:num><akn:heading>Grounds for refusing application; approval of application; factors; “substantial evidence” defined; combination drugs</akn:heading><akn:content><akn:p>(d) Grounds for refusing application; approval of application; factors; “substantial evidence” defined; combination drugs</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_e"><akn:num>(e)</akn:num><akn:heading>Withdrawal of approval; grounds; immediate suspension upon finding imminent hazard to health of man or animals</akn:heading><akn:content><akn:p>(e) Withdrawal of approval; grounds; immediate suspension upon finding imminent hazard to health of man or animals</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_f"><akn:num>(f)</akn:num><akn:heading>Revocation of order refusing, withdrawing or suspending approval of application</akn:heading><akn:content><akn:p>(f) Revocation of order refusing, withdrawing or suspending approval of application Whenever the Secretary finds that the facts so require, he shall revoke any previous order under subsection (d), (e), or (m), or section 360ccc(c), (d), or (e) of this title refusing, withdrawing, or suspending approval of an application and shall approve such application or reinstate such approval, as may be appropriate.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_g"><akn:num>(g)</akn:num><akn:heading>Service of orders</akn:heading><akn:content><akn:p>(g) Service of orders Orders of the Secretary issued under this section, or section 360ccc of this title (other than orders issuing, amending, or repealing regulations) shall be served (1) in person by any officer or employee of the department designated by the Secretary or (2) by mailing the order by registered mail or by certified mail addressed to the applicant or respondent at his last known address in the records of the Secretary.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_h"><akn:num>(h)</akn:num><akn:heading>Appeal from order</akn:heading><akn:content><akn:p>(h) Appeal from order An appeal may be taken by the applicant from an order of the Secretary refusing or withdrawing approval of an application filed under subsection (b) or (m) of this section. The provisions of subsection (h) of section 355 of this title shall govern any such appeal.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_i"><akn:num>(i)</akn:num><akn:heading>Publication in Federal Register; effective date and revocation or suspension of regulation</akn:heading><akn:content><akn:p>(i) Publication in Federal Register; effective date and revocation or suspension of regulation When a new animal drug application filed pursuant to subsection (b) or section 360ccc of this title is approved, the Secretary shall by notice, which upon publication shall be effective as a regulation, publish in the Federal Register the name and address of the applicant and the conditions and indications of use of the new animal drug covered by such application, including any tolerance and withdrawal period or other use restrictions and, if such new animal drug is intended for use in animal feed, appropriate purposes and conditions of use (including special labeling requirements and any requirement that an animal feed bearing or containing the new animal drug be limited to use under the professional supervision of a licensed veterinarian) applicable to any animal feed for use in which such drug is approved, and such other information, upon the basis of which such application was approved, a</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360b_j"><akn:num>(j)</akn:num><akn:heading>Exemption of drugs for research; discretionary and mandatory conditions</akn:heading><akn:content><akn:p>(j) Exemption of drugs for research; discretionary and mandatory conditions To the extent consistent with the public health, the Secretary shall promulgate regulations for exempting from the operation of this section new animal drugs, and animal feeds bearing or containing new animal drugs, intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of animal drugs. Such regulations may, in the discretion of the Secretary, among other conditions relating to the protection of the public health, provide for conditioning such exemption upon the establishment and maintenance of such records, and the making of such reports to the Secretary, by the manufacturer or the sponsor of the investigation of such article, of data (including but not limited to analytical reports by investigators) obtained as a result of such investigational use of such article, as the Secretary finds will enable him to evaluate the safe</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>